» Articles » PMID: 38155321

Aptamer-functionalized MOFs and AI-driven Strategies for Early Cancer Diagnosis and Therapeutics

Overview
Journal Biotechnol Lett
Date 2023 Dec 28
PMID 38155321
Authors
Affiliations
Soon will be listed here.
Abstract

Metal-Organic Frameworks (MOFs) have exceptional inherent properties that make them highly suitable for diverse applications, such as catalysis, storage, optics, chemo sensing, and biomedical science and technology. Over the past decades, researchers have utilized various techniques, including solvothermal, hydrothermal, mechanochemical, electrochemical, and ultrasonic, to synthesize MOFs with tailored properties. Post-synthetic modification of linkers, nodal components, and crystallite domain size and morphology can functionalize MOFs to improve their aptamer applications. Advancements in AI and machine learning led to the development of nonporous MOFs and nanoscale MOFs for medical purposes. MOFs have exhibited promise in cancer therapy, with the successful accumulation of a photosensitizer in cancer cells representing a significant breakthrough. This perspective is focused on MOFs' use as advanced materials and systems for cancer therapy, exploring the challenging aspects and promising features of MOF-based cancer diagnosis and treatment. The paper concludes by emphasizing the potential of MOFs as a transformative technology for cancer treatment and diagnosis.

Citing Articles

Understanding the Electrochemical MOF Sensors in Detecting Cancer with Special Emphasis on Breast Carcinoma Biomarkers.

Mohan B, Modi K, Singh G, Paul A, Garazade I, Pombeiro A Top Curr Chem (Cham). 2025; 383(1):9.

PMID: 39966301 DOI: 10.1007/s41061-025-00493-0.


Breaking Barriers: Nucleic Acid Aptamers in Gastrointestinal (GI) Cancers Therapy.

Uinarni H, Oghenemaro E, Menon S, Hjazi A, Ibrahim F, Kaur M Cell Biochem Biophys. 2024; 82(3):1763-1776.

PMID: 38916791 DOI: 10.1007/s12013-024-01367-w.

References
1.
Albeshan S, Hossain S, Mackey M, Brennan P . Can Breast Self-examination and Clinical Breast Examination Along With Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations With Advanced Stages at Diagnosis?. Clin Breast Cancer. 2020; 20(3):194-200. DOI: 10.1016/j.clbc.2020.02.001. View

2.
Cai M, Chen G, Qin L, Qu C, Dong X, Ni J . Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer. Pharmaceutics. 2020; 12(3). PMC: 7150757. DOI: 10.3390/pharmaceutics12030232. View

3.
Campos-Fernandez E, Alqualo N, Moura Garcia L, Coutinho Horacio Alves C, Ferreira Arantes Vieira T, Moreira D . The use of aptamers in prostate cancer: A systematic review of theranostic applications. Clin Biochem. 2021; 93:9-25. DOI: 10.1016/j.clinbiochem.2021.03.014. View

4.
Campuzano S, Yanez-Sedeno P, Pingarron J . Nanoparticles for nucleic-acid-based biosensing: opportunities, challenges, and prospects. Anal Bioanal Chem. 2018; 411(9):1791-1806. DOI: 10.1007/s00216-018-1273-6. View

5.
Capello M, Bantis L, Scelo G, Zhao Y, Li P, Dhillon D . Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017; 109(4). PMC: 5441297. DOI: 10.1093/jnci/djw266. View